Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	actin filament binding	VIL1 CACNB2 MYH9 PPP1R9A FMNL2 IQGAP1 KPTN FMNL3	2.67e-05	227	105	8	GO:0051015
GeneOntologyBiologicalProcess	protein autophosphorylation	FLT4 CDK12 STK17B INSRR IQGAP1 STK16 CSNK2A1 KDR MARK2	2.33e-06	228	104	9	GO:0046777
GeneOntologyCellularComponent	protein kinase CK2 complex	CSNK2A1 CSNK2A3	1.49e-04	4	105	2	GO:0005956
GeneOntologyCellularComponent	actin cytoskeleton	VIL1 MYH9 STK17B PPP1R9A IFIT5 IQGAP1 KPTN DOCK5 BAIAP2L1 MARK2 TNNT1	1.52e-04	576	105	11	GO:0015629
Domain	MORN	ANKMY1 RSPH1 SETD7	7.91e-05	15	107	3	IPR003409
Domain	MORN	ANKMY1 RSPH1 SETD7	7.91e-05	15	107	3	PF02493
Domain	Myosin-like_IQ_dom	MYH9 IQGAP1 ASPM	1.66e-04	19	107	3	IPR027401
Domain	-	MYH9 IQGAP1 ASPM	1.66e-04	19	107	3	4.10.270.10
Domain	PROTEIN_KINASE_ATP	FLT4 CDK12 STK17B INSRR CDC7 STK16 CSNK2A1 KDR MARK2 CSNK2A3	3.05e-04	459	107	10	PS00107
Domain	PP2A_B56	PPP2R5C PPP2R5E	3.22e-04	5	107	2	IPR002554
Domain	B56	PPP2R5C PPP2R5E	3.22e-04	5	107	2	PF01603
Domain	Protein_kinase_ATP_BS	FLT4 CDK12 STK17B INSRR CDC7 CSNK2A1 KDR MARK2 CSNK2A3	3.31e-04	379	107	9	IPR017441
Domain	TPR_10	IFIT5 KLC1	4.80e-04	6	107	2	PF13374
Domain	Prot_kinase_dom	FLT4 CDK12 STK17B INSRR CDC7 STK16 CSNK2A1 KDR MARK2 CSNK2A3	5.02e-04	489	107	10	IPR000719
Domain	PROTEIN_KINASE_DOM	FLT4 CDK12 STK17B INSRR CDC7 STK16 CSNK2A1 KDR MARK2 CSNK2A3	5.35e-04	493	107	10	PS50011
Domain	ARM-type_fold	FMNL2 FMNL3 DOCK5 PPP2R5C PPP2R5E ASPM RIPOR1 WDFY3	7.44e-04	339	107	8	IPR016024
Domain	Tyr_kinase_rcpt_3_CS	FLT4 KDR	8.90e-04	8	107	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT4 KDR	8.90e-04	8	107	2	PS00240
Domain	Kinase-like_dom	FLT4 CDK12 STK17B INSRR CDC7 STK16 CSNK2A1 KDR MARK2 CSNK2A3	1.10e-03	542	107	10	IPR011009
Domain	Drf_GBD	FMNL2 FMNL3	1.14e-03	9	107	2	PF06371
Domain	Drf_FH3	FMNL2 FMNL3	1.14e-03	9	107	2	PF06367
Domain	FH3_dom	FMNL2 FMNL3	1.14e-03	9	107	2	IPR010472
Domain	GTPase-bd	FMNL2 FMNL3	1.14e-03	9	107	2	IPR010473
Domain	Drf_FH3	FMNL2 FMNL3	1.14e-03	9	107	2	SM01139
Domain	Drf_GBD	FMNL2 FMNL3	1.14e-03	9	107	2	SM01140
Domain	-	ST7 IFIT5 TTC34 WDR19 TOMM34 KLC1	1.23e-03	207	107	6	1.25.40.10
Domain	Anoctamin	ANO4 ANO8	1.42e-03	10	107	2	PF04547
Domain	Anoctamin	ANO4 ANO8	1.42e-03	10	107	2	IPR007632
Domain	TPR-contain_dom	IFIT5 TTC34 WDR19 TOMM34 KLC1	1.72e-03	150	107	5	IPR013026
Domain	GBD/FH3_dom	FMNL2 FMNL3	1.73e-03	11	107	2	IPR014768
Domain	GBD_FH3	FMNL2 FMNL3	1.73e-03	11	107	2	PS51232
Domain	TPR-like_helical_dom	ST7 IFIT5 TTC34 WDR19 TOMM34 KLC1	2.24e-03	233	107	6	IPR011990
Domain	WW	HECW1 FNBP4 IQGAP1	2.47e-03	47	107	3	PF00397
Domain	TPR_REGION	IFIT5 TTC34 WDR19 TOMM34 KLC1	2.61e-03	165	107	5	PS50293
Domain	TPR	IFIT5 TTC34 WDR19 TOMM34 KLC1	2.61e-03	165	107	5	PS50005
Domain	WW	HECW1 FNBP4 IQGAP1	2.62e-03	48	107	3	SM00456
Domain	SEA	MUC1 AGRN	2.83e-03	14	107	2	SM00200
Domain	MORN	ANKMY1 RSPH1	2.83e-03	14	107	2	SM00698
Domain	WW_DOMAIN_1	HECW1 FNBP4 IQGAP1	3.12e-03	51	107	3	PS01159
Domain	WW_DOMAIN_2	HECW1 FNBP4 IQGAP1	3.12e-03	51	107	3	PS50020
Domain	-	MUC1 AGRN	3.25e-03	15	107	2	3.30.70.960
Domain	FH2	FMNL2 FMNL3	3.25e-03	15	107	2	PS51444
Domain	FH2_Formin	FMNL2 FMNL3	3.25e-03	15	107	2	IPR015425
Domain	FH2	FMNL2 FMNL3	3.25e-03	15	107	2	PF02181
Domain	FH2	FMNL2 FMNL3	3.25e-03	15	107	2	SM00498
Domain	WW_dom	HECW1 FNBP4 IQGAP1	3.30e-03	52	107	3	IPR001202
Domain	Ser/Thr_kinase_AS	CDK12 STK17B CDC7 STK16 CSNK2A1 MARK2 CSNK2A3	4.48e-03	357	107	7	IPR008271
Domain	S_TKc	CDK12 STK17B CDC7 STK16 CSNK2A1 MARK2 CSNK2A3	4.62e-03	359	107	7	SM00220
Domain	PROTEIN_KINASE_ST	CDK12 STK17B CDC7 STK16 CSNK2A1 MARK2 CSNK2A3	4.83e-03	362	107	7	PS00108
Pathway	KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT	CSNK2A1 CSNK2A3 KLC1	5.20e-05	13	82	3	M47763
Pathway	REACTOME_NCAM1_INTERACTIONS	CACNB2 COL6A6 CACNA1I AGRN	1.01e-04	42	82	4	M7169
Pubmed	The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.	ADRM1 FMNL3 PPP2R5C SCCPDH PPP2R5E GTF3C1 WDR11 TOMM34 KLC1	7.82e-07	325	107	9	36168628
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	LRP12 TENT4A FMNL2 FMNL3 GTF3C1 WDR11 CSNK2A1 ATP11C	5.93e-06	313	107	8	38270169
Pubmed	An integrated genetic, radiation hybrid, physical and transcription map of a region of distal mouse chromosome 12, including an imprinted locus and the 'Legs at odd angles' (Loa) mutation.	PPP2R5C PPP2R5E KLC1	6.10e-06	12	107	3	11867214
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCDC1 POLR2C FMNL2 PARS2 PPP2R5E NT5DC2 CSNK2A1 IL21R ASPM ELF3 RERE WDFY3 SIPA1L2 TSR3	8.58e-06	1116	107	14	31753913
Pubmed	IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.	IQGAP1 KDR	9.38e-06	2	107	2	15217908
Pubmed	Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2.	CSNK2A1 CSNK2A3	9.38e-06	2	107	2	14646071
Pubmed	VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts.	FLT4 KDR	9.38e-06	2	107	2	20224550
Pubmed	VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.	FLT4 KDR	9.38e-06	2	107	2	25399804
Pubmed	[Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].	FLT4 KDR	9.38e-06	2	107	2	21163065
Pubmed	Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages.	FLT4 KDR	9.38e-06	2	107	2	21273538
Pubmed	A strategy to identify protein-N-myristoylation-dependent phosphorylation reactions of cellular proteins by using Phos-tag SDS-PAGE.	FMNL2 FMNL3	9.38e-06	2	107	2	31751425
Pubmed	Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.	CSNK2A1 CSNK2A3	9.38e-06	2	107	2	12860116
Pubmed	Conserved signaling through vascular endothelial growth (VEGF) receptor family members in murine lymphatic endothelial cells.	FLT4 KDR	9.38e-06	2	107	2	21839079
Pubmed	Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3.	FLT4 KDR	9.38e-06	2	107	2	12393458
Pubmed	A Role of Agrin in Maintaining the Stability of Vascular Endothelial Growth Factor Receptor-2 during Tumor Angiogenesis.	KDR AGRN	9.38e-06	2	107	2	31340156
Pubmed	Anti-angiogenic and pro-apoptotic effects of a small-molecule JFD-WS in in vitro and breast cancer xenograft mouse models.	KDR MUC1	9.38e-06	2	107	2	29436685
Pubmed	Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2.	PDCD6 KDR	9.38e-06	2	107	2	21893193
Pubmed	VEGF receptor subtypes may serve as novel prognostic factors and putative indicators for anti VEGF receptor treatment response in renal cell carcinoma cases.	FLT4 KDR	9.38e-06	2	107	2	27837630
Pubmed	Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity.	FLT4 KDR	9.38e-06	2	107	2	15474514
Pubmed	Assignment of casein kinase 2 alpha sequences to two different human chromosomes.	CSNK2A1 CSNK2A3	9.38e-06	2	107	2	1577469
Pubmed	FMNL formins boost lamellipodial force generation.	FMNL2 FMNL3	9.38e-06	2	107	2	28327544
Pubmed	Protein N-myristoylation is required for cellular morphological changes induced by two formin family proteins, FMNL2 and FMNL3.	FMNL2 FMNL3	9.38e-06	2	107	2	22790947
Pubmed	Molecular cloning of the human casein kinase II alpha subunit.	CSNK2A1 CSNK2A3	9.38e-06	2	107	2	2752008
Pubmed	Structure and sequence of an intronless gene for human casein kinase II-alpha subunit.	CSNK2A1 CSNK2A3	9.38e-06	2	107	2	8420794
Pubmed	Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?	FLT4 MUC1	9.38e-06	2	107	2	32160452
Pubmed	Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.	FLT4 KDR	9.38e-06	2	107	2	20606037
Pubmed	Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens.	FLT4 KDR	9.38e-06	2	107	2	12867434
Pubmed	Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis.	FLT4 KDR	9.38e-06	2	107	2	17210781
Pubmed	Expansion of cortical and medullary sinuses restrains lymph node hypertrophy during prolonged inflammation.	FLT4 KDR	9.38e-06	2	107	2	22430738
Pubmed	Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.	FLT4 KDR	9.38e-06	2	107	2	17535974
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MYH9 CDK12 POLB ACLY TBCB IGF2BP1 PPP2R5C SCCPDH NT5DC2	2.44e-05	498	107	9	36634849
Pubmed	Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation.	CSNK2A1 CSNK2A3	2.81e-05	3	107	2	15684395
Pubmed	The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.	FLT4 KDR	2.81e-05	3	107	2	16530705
Pubmed	Early endocardial morphogenesis requires Scl/Tal1.	FLT4 KDR	2.81e-05	3	107	2	17722983
Pubmed	Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.	FLT4 KDR	2.81e-05	3	107	2	21635552
Pubmed	Isolation and characterization of human cDNA clones encoding the alpha and the alpha' subunits of casein kinase II.	CSNK2A1 CSNK2A3	2.81e-05	3	107	2	2174700
Pubmed	Generating Vegfr3 reporter transgenic mouse expressing membrane-tagged Venus for visualization of VEGFR3 expression in vascular and lymphatic endothelial cells.	FLT4 KDR	2.81e-05	3	107	2	30601868
Pubmed	Interplay of vascular endothelial growth factor receptors in organ-specific vessel maintenance.	FLT4 KDR	2.81e-05	3	107	2	35050301
Pubmed	Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.	FLT4 KDR	2.81e-05	3	107	2	24713547
Pubmed	Mapping of the human casein kinase II catalytic subunit genes: two loci carrying the homologous sequences for the alpha subunit.	CSNK2A1 CSNK2A3	2.81e-05	3	107	2	1766873
Pubmed	The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®).	FLT4 KDR	2.81e-05	3	107	2	25340839
Pubmed	The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.	FLT4 KDR	2.81e-05	3	107	2	11279005
Pubmed	Autotaxin and vascular endothelial growth factor receptor-2 and -3 are related to vascular development during the progression of chronic viral hepatitis C.	FLT4 KDR	2.81e-05	3	107	2	30456868
Pubmed	Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization.	FLT4 KDR	2.81e-05	3	107	2	21130043
Pubmed	Crystallization and preliminary characterization of crystals of human protein kinase CK2.	CSNK2A1 CSNK2A3	2.81e-05	3	107	2	11092945
Pubmed	Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.	FLT4 KDR	2.81e-05	3	107	2	24845798
Pubmed	Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.	FLT4 KDR	2.81e-05	3	107	2	29787601
Pubmed	Sequencing of full-length cDNA encoding the alpha and beta subunits of human casein kinase II from human platelets and megakaryocytic cells. Expression of the casein kinase IIalpha intronless gene in a megakaryocytic cell line.	CSNK2A1 CSNK2A3	2.81e-05	3	107	2	12102635
Pubmed	Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis.	FLT4 KDR	2.81e-05	3	107	2	11574540
Pubmed	Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).	FLT4 KDR	2.81e-05	3	107	2	9435229
Pubmed	IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.	IQGAP1 KDR	2.81e-05	3	107	2	19050761
Pubmed	Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.	CSNK2A1 CSNK2A3	2.81e-05	3	107	2	20625391
Pubmed	Angiogenesis interactome and time course microarray data reveal the distinct activation patterns in endothelial cells.	FLT4 KDR	2.81e-05	3	107	2	25329517
Pubmed	Expression and localization of VEGF receptors in human fetal skeletal tissues.	FLT4 KDR	2.81e-05	3	107	2	23059888
Pubmed	Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico.	FMNL2 FMNL3	2.81e-05	3	107	2	12684686
Pubmed	Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms.	FLT4 KDR	2.81e-05	3	107	2	29615616
Pubmed	Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot.	FLT4 KDR	2.81e-05	3	107	2	30232381
Pubmed	Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.	FLT4 KDR	2.81e-05	3	107	2	22542663
Pubmed	IQGAP1 causes choroidal neovascularization by sustaining VEGFR2-mediated Rac1 activation.	IQGAP1 KDR	2.81e-05	3	107	2	32783108
Pubmed	Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.	FLT4 KDR	2.81e-05	3	107	2	25909285
Pubmed	Signaling via vascular endothelial growth factor receptors.	FLT4 KDR	2.81e-05	3	107	2	10579917
Pubmed	Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.	FLT4 KDR	2.81e-05	3	107	2	19068081
Pubmed	Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.	FLT4 KDR	2.81e-05	3	107	2	10887117
Pubmed	All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.	FLT4 KDR	2.81e-05	3	107	2	14687619
Pubmed	Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.	FLT4 KDR	2.81e-05	3	107	2	28718364
Pubmed	Possible genetic predisposition to lymphedema after breast cancer.	FLT4 KDR	2.81e-05	3	107	2	22404826
Pubmed	Expression of receptors for VEGFs on normal human thyroid follicular cells and their role in follicle formation.	FLT4 KDR	2.81e-05	3	107	2	21751212
Pubmed	uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.	FLT4 KDR	2.81e-05	3	107	2	30518756
Pubmed	FMNL2 and -3 regulate Golgi architecture and anterograde transport downstream of Cdc42.	FMNL2 FMNL3	2.81e-05	3	107	2	28852060
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MYH9 CDK12 POLR2C RPS8 FNBP4 PARS2 IGF2BP1 GTF3C1 CSNK2A1 SIPA1L2 TSR3 AGRN TNXB	2.89e-05	1082	107	13	38697112
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	PDCD6 RPS8 IQGAP1 IGF2BP1 PPP2R5C PPP2R5E CSNK2A1 MARK2 SIPA1L2 AGRN	2.90e-05	639	107	10	23443559
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNB2 MYH9 ACLY PPP1R9A RPS8 CNTNAP1 FMNL2 IQGAP1 PPP2R5E LZTS1 CSNK2A1 ATP6V1D MARK2 SIPA1L2 KLC1	3.29e-05	1431	107	15	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VIL1 MYH9 PPP1R9A IFIT5 IQGAP1 ZNF675 TBCB SCCPDH GTF3C1 ASPM ATP11C KDR MCF2L SIPA1L2 TNNT1	3.59e-05	1442	107	15	35575683
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	VIL1 MYH9 ACLY IQGAP1 KPTN STK16 IGF2BP1 ARR3 LOXHD1 CSNK2A1 ASPM ELF3 MARK2 KLC1	4.03e-05	1284	107	14	17353931
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	MYH9 RPS8 IQGAP1 PPP2R5C PPP2R5E GTF3C1 ENO3 KLC1	4.18e-05	411	107	8	36652389
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB2 MYH9 HECW1 PPP1R9A CNTNAP1 IQGAP1 LZTS1 CSNK2A1 SH3D19 WDFY3 AGRN KLC1	4.22e-05	963	107	12	28671696
Pubmed	Label-Free Neuroproteomics of the Hippocampal-Accumbal Circuit Reveals Deficits in Neurotransmitter and Neuropeptide Signaling in Mice Lacking Ethanol-Sensitive Adenosine Transporter.	PCSK1 PDYN	5.60e-05	4	107	2	27998058
Pubmed	VEGFR3 modulates brain microvessel branching in a mouse model of 22q11.2 deletion syndrome.	FLT4 KDR	5.60e-05	4	107	2	36216515
Pubmed	[Comparative immunohistochemical evaluation of vascular endothelial growth factor and its receptors in the placental villi in gestational diabetes mellitus and type 1 diabetes].	FLT4 KDR	5.60e-05	4	107	2	24341227
Pubmed	Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.	FLT4 KDR	5.60e-05	4	107	2	22016416
Pubmed	Differential expression of VEGF ligands and receptors in prostate cancer.	FLT4 KDR	5.60e-05	4	107	2	23038639
Pubmed	VEGFR3 is required for button junction formation in lymphatic vessels.	FLT4 KDR	5.60e-05	4	107	2	37454290
Pubmed	Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.	MYH9 CSNK2A1	5.60e-05	4	107	2	16186248
Pubmed	Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.	FLT4 KDR	5.60e-05	4	107	2	28680264
Pubmed	Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.	FLT4 KDR	5.60e-05	4	107	2	19636022
Pubmed	KIF4A and PP2A-B56 form a spatially restricted feedback loop opposing Aurora B at the anaphase central spindle.	PPP2R5C PPP2R5E	5.60e-05	4	107	2	25512391
Pubmed	VEGFR3 does not sustain retinal angiogenesis without VEGFR2.	FLT4 KDR	5.60e-05	4	107	2	25561555
Pubmed	Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma.	FLT4 KDR	5.60e-05	4	107	2	11807987
Pubmed	VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.	FLT4 KDR	5.60e-05	4	107	2	28298294
Pubmed	Lymphatic ontogeny and effect of hypoplasia in developing lung.	FLT4 KDR	5.60e-05	4	107	2	20932899
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	ACLY RPS8 GTPBP10 IGF2BP1 ASPM MARK2 CSNK2A3	5.74e-05	316	107	7	31665637
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ACLY IQGAP1 PPP2R5C SCCPDH PPP2R5E BAIAP2L1 WDR11 NT5DC2 SETD7	6.04e-05	560	107	9	35241646
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	ADRM1 ACLY POLR2C RPS8 PARS2 IQGAP1 IGF2BP1 LSM6 PPP2R5E GTF3C1 WDR11 NT5DC2 CSNK2A1 TOMM34	6.13e-05	1335	107	14	29229926
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	VIL1 DPYS MYH9 PDCD6 ACLY PDZK1 CP IQGAP1 BAIAP2L1 ATP6V1D RIPOR1 MUC1	7.03e-05	1016	107	12	19056867
Pubmed	The variable subunit associated with protein phosphatase 2A0 defines a novel multimember family of regulatory subunits.	PPP2R5C PPP2R5E	9.32e-05	5	107	2	8694763
Pubmed	Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12.	PPP2R5C PPP2R5E	9.32e-05	5	107	2	8812429
Pubmed	Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.	FLT4 KDR	9.32e-05	5	107	2	26735859
Pubmed	Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.	FLT4 KDR	9.32e-05	5	107	2	19066962
Pubmed	Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.	FLT4 KDR	9.32e-05	5	107	2	23219511
Pubmed	Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice.	PPP2R5C PPP2R5E	9.32e-05	5	107	2	15095873
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT4 INSRR KDR	5.17e-04	40	71	3	321
GeneFamily	Anoctamins	ANO4 ANO8	6.70e-04	10	71	2	865
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	IFIT5 TTC34 TOMM34 KLC1	1.09e-03	115	71	4	769
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R5C PPP2R5E	1.54e-03	15	71	2	696
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 CP BAIAP2L1 RSPH1 SH3D19 ELF3 MUC1	5.17e-07	198	107	7	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 TNNT1 MUC1	5.20e-06	182	107	6	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNB2 ASPN FMNL2 DOCK5 TNXB	5.36e-06	183	107	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 TNNT1 MUC1	5.36e-06	183	107	6	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 TNNT1 MUC1	5.53e-06	184	107	6	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 TNNT1 MUC1	5.71e-06	185	107	6	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL2 FMNL3 GBP4 KDR TNXB	6.85e-06	191	107	6	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	FLT4 FMNL3 LOXHD1 ATP11C KDR SIPA1L2	7.06e-06	192	107	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 ASPN FMNL3 GBP4 KDR MCF2L	7.27e-06	193	107	6	3a5090f81f35026f435f4a250d1e77601a53af15
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 ASPN FMNL3 GBP4 KDR MCF2L	7.27e-06	193	107	6	13731b7fc1e3bec0cebc44bad7e2ecea358bb76a
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 ASPN FMNL3 GBP4 KDR MCF2L	7.27e-06	193	107	6	88cd7d0d0da5c776b49fc131f746fe5ad9676fb7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 POLB FMNL2 GBP4 KDR TNXB	7.49e-06	194	107	6	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRP12 PPP1R9A CP B3GAT1 ELF3 MCF2L	8.91e-06	200	107	6	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	distal-2-Epithelial\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 CP BAIAP2L1 RSPH1 ELF3 MUC1	8.91e-06	200	107	6	2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	VIL1 FLT4 COL6A6 GBP4 MUC1	1.62e-05	131	107	5	d5bc40cd585582856881081b7130dec3515b4ae0
ToppCell	COVID-CD4-antiviral_CD4\|COVID / Condition, Cell_class and T cell subcluster	CACNB2 FLT4 IFIT5 B3GAT1 CACNA1I	3.64e-05	155	107	5	7e5ae034036fe85915d38a24195501e6d3bcbfb0
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK1 HECW1 CSMD3 CNTN6 USP26	4.50e-05	162	107	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PARS2 NT5C1A IL21R CACNA1I SIPA1L2	4.77e-05	164	107	5	875d922eec7e3df0998ddf0c8c4dee2dcd5b23ca
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 MUC1	6.31e-05	174	107	5	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PPP1R9A CNTN6 SH3D19 ELF3	6.84e-05	177	107	5	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 PDZK1 FMNL3 KDR MCF2L	7.03e-05	178	107	5	a3f95f0002f408b5b6c57e28b297b5b2737e919c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNB2 ASPN CNTNAP1 TNXB	7.22e-05	179	107	5	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	droplet-Fat-Gat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 ZGRF1 GBP4 KDR MCF2L	7.22e-05	179	107	5	08cf9986804a6417a9afb19b50c69a3554f71ec6
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 MUC1	7.81e-05	182	107	5	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	Club-club-8\|World / Class top	ASPN CP FETUB MUC1 TNXB	7.81e-05	182	107	5	8111d917e588008d947021460ddf8f1e7ae1337a
ToppCell	facs\|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP53 VIL1 IQGAP1 BAIAP2L1 ELF3	7.81e-05	182	107	5	08f775135b451be709f5fc8e1cbcf63425794a2e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PXMP4 CP BAIAP2L1 ELF3 MUC1	7.81e-05	182	107	5	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL3 DOCK5 KDR TNXB	7.81e-05	182	107	5	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL3 DOCK5 KDR TNXB	7.81e-05	182	107	5	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL3 DOCK5 KDR TNXB	7.81e-05	182	107	5	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	FLT4 FMNL3 GBP4 KDR TNXB	8.01e-05	183	107	5	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN6 BAIAP2L1 ELF3 TNNT1 MUC1	8.01e-05	183	107	5	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP BAIAP2L1 ELF3 TNNT1 MUC1	8.22e-05	184	107	5	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	PPP1R9A CP BAIAP2L1 ELF3 MUC1	8.43e-05	185	107	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	USP53 CACNB2 COL6A6 SH3D19 TNXB	8.87e-05	187	107	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma\|TCGA-Kidney / Sample_Type by Project: Shred V9	CP FMNL3 GBP4 LZTS1 KDR	9.09e-05	188	107	5	e711c7a46d7cfa030ca2982eacc1dae5af5788dd
ToppCell	Pericytes-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	ANO4 CACNB2 HECW1 ASPN LZTS1	9.09e-05	188	107	5	f16ff998393bf1954bbf10caab15173bdb104ac1
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 FMNL3 KDR MCF2L AGRN	9.09e-05	188	107	5	0026c9479b30fb39daa91cfa220a88f9c9e65fe7
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 MUC1	9.09e-05	188	107	5	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	facs-Lung-EPCAM-24m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPIL6 RSPH1 ELF3 GRHL3 MUC1	9.09e-05	188	107	5	c2ef270f691d367b1621d48f0771267cefe1630d
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	PPP1R9A DOCK5 BAIAP2L1 ELF3 MUC1	9.09e-05	188	107	5	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP CNTN6 BAIAP2L1 ELF3 MUC1	9.32e-05	189	107	5	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	facs-Heart-LV-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 FLT4 GBP4 KDR MCF2L	9.32e-05	189	107	5	d424d2554595b2304219f7324406b401711af7c2
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATP11C RIPOR1 KDR MCF2L SIPA1L2	9.32e-05	189	107	5	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 FLT4 GBP4 KDR MCF2L	9.32e-05	189	107	5	393ec5954a12d6cf67bb435dcc34ff0b14c81e9f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DPYS DCDC1 HECW1 PDZK1 PPP1R9A	9.32e-05	189	107	5	28b502611829e4a24caff2562545c7db97686099
ToppCell	facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 FLT4 GBP4 KDR MCF2L	9.32e-05	189	107	5	bec57459ad4bab15b2532b57722549fec2e771fb
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 FMNL3 GBP4 KDR MCF2L	9.56e-05	190	107	5	632d5dc11765053366d61f0a0c7916111cea4f50
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPIL6 BAIAP2L1 RSPH1 ELF3 MUC1	9.56e-05	190	107	5	edc0a0eb17abbecb0f06d302be3d4f8c1dd4f333
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	PPP1R9A CP BAIAP2L1 ELF3 MUC1	9.56e-05	190	107	5	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DCDC1 CP RSPH1 ELF3 MUC1	9.80e-05	191	107	5	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 FMNL3 RIPOR1 KDR MCF2L	9.80e-05	191	107	5	79b399496bd7322a1d53c43378f48695fd09a5d9
ToppCell	facs-Trachea-24m-Endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 FMNL3 RIPOR1 KDR MCF2L	9.80e-05	191	107	5	9c6d5d045781c6506ae80e318427ef1e0d87f45c
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DCDC1 CP RSPH1 ELF3 MUC1	9.80e-05	191	107	5	5129f778a9283bfac4ff322c21c5ca71da4b7174
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 FMNL3 RIPOR1 KDR MCF2L	9.80e-05	191	107	5	1b1e943709d0c3283a980c7c965ef1f110506a29
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 VIL1 ACLY SQLE INSRR	9.80e-05	191	107	5	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DCDC1 CP RSPH1 ELF3 MUC1	9.80e-05	191	107	5	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	DCDC1 CP RSPH1 ELF3 MUC1	9.80e-05	191	107	5	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DCDC1 CP RSPH1 ELF3 MUC1	9.80e-05	191	107	5	c50d6a1a6209ed4157f7c00fc24d4ecb43790f44
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 CACNB2 COL6A6 SH3D19 TNXB	9.80e-05	191	107	5	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPP1R9A CP ELF3 KDR MUC1	1.00e-04	192	107	5	c227ab1914191e839fc39c9adc2080026d4b04fc
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 VIL1 ACLY SQLE INSRR	1.00e-04	192	107	5	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPP1R9A CP ELF3 KDR MUC1	1.00e-04	192	107	5	bf187a57a559ab732bb815892af45ca922966ac6
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 CP FMNL3 KDR MCF2L	1.00e-04	192	107	5	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPP1R9A CP ELF3 KDR MUC1	1.00e-04	192	107	5	f573b2d205bd4d053a548af3fe3ff9de7be0cd2b
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Club\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CP ELF3 KDR GRHL3 MUC1	1.00e-04	192	107	5	044c7ae56da17cacf2705efa8ac2c8aeba6cfeee
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 CACNB2 COL6A6 SH3D19 TNXB	1.00e-04	192	107	5	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 FLT4 FMNL3 KDR MCF2L	1.00e-04	192	107	5	9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 FLT4 FMNL3 KDR MCF2L	1.00e-04	192	107	5	a116db7dec495e5a0ba9c7537057cd1e567d7885
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 FLT4 FMNL3 KDR MCF2L	1.00e-04	192	107	5	66defad13bd8e79319741e43ddb056841710b1d7
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP1R9A RIPOR1 KDR MCF2L SIPA1L2	1.03e-04	193	107	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP1R9A RIPOR1 KDR MCF2L SIPA1L2	1.03e-04	193	107	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	droplet-Bladder-nan-3m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASPN FMNL3 GBP4 KDR MCF2L	1.03e-04	193	107	5	8be24713f8ba2545b7647d1994e9e993623ddaa3
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP1R9A SH3D19 KDR MCF2L SIPA1L2	1.03e-04	193	107	5	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	droplet-Bladder-nan-3m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASPN FMNL3 GBP4 KDR MCF2L	1.03e-04	193	107	5	19dfc4a2c91fcea4f5991e7c44df46faeecb06b8
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CP DOCK5 BAIAP2L1 ELF3 GRHL3	1.03e-04	193	107	5	0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b
ToppCell	droplet-Bladder-nan-3m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASPN FMNL3 GBP4 KDR MCF2L	1.03e-04	193	107	5	351e0acd411a9eb0dbc0e358d0d1e3759753fa40
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	USP53 CACNB2 COL6A6 CSMD3 SH3D19	1.05e-04	194	107	5	5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	USP53 CACNB2 COL6A6 CSMD3 SH3D19	1.05e-04	194	107	5	99577a5a631e607b5abe7a1b0d8d6a5eabe50196
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL2 FMNL3 KDR TNXB	1.05e-04	194	107	5	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	FLT4 FMNL3 KDR MCF2L SIPA1L2	1.08e-04	195	107	5	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	USP53 CACNB2 COL6A6 SH3D19 TNXB	1.08e-04	195	107	5	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	USP53 CACNB2 COL6A6 SH3D19 TNXB	1.08e-04	195	107	5	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 ACLY INSRR IQGAP1 RERE	1.08e-04	195	107	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 VIL1 ACLY SQLE INSRR	1.08e-04	195	107	5	58b769da05a8f6b05aeb08d4f8b112941087ad00
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 ACLY INSRR IQGAP1 RERE	1.08e-04	195	107	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	ASK454-Endothelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYH9 FLT4 KDR CAPS2 TNXB	1.11e-04	196	107	5	14dd6956ef420b660be0baf52a66960e57d75d16
ToppCell	ASK454-Endothelial-Endothelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYH9 FLT4 KDR CAPS2 TNXB	1.11e-04	196	107	5	2b777a2026b56839112fd179f2db482c49f4594a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL3 GBP4 KDR SIPA1L2	1.11e-04	196	107	5	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPIL6 CP RSPH1 ELF3 MUC1	1.11e-04	196	107	5	3e99a367b7d817e1f1221450fcec20ad7a7c7a2a
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPIL6 CP RSPH1 ELF3 MUC1	1.11e-04	196	107	5	1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 CACNB2 COL6A6 SH3D19 TNXB	1.11e-04	196	107	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	FLT4 FMNL3 KDR MCF2L SIPA1L2	1.11e-04	196	107	5	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 CACNB2 COL6A6 SH3D19 TNXB	1.11e-04	196	107	5	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CP FMNL2 KDR MCF2L SIPA1L2	1.13e-04	197	107	5	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 FMNL3 GBP4 KDR TNXB	1.13e-04	197	107	5	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	Bronchial_Brush-Epithelial\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 CP RSPH1 ELF3 MUC1	1.13e-04	197	107	5	272c7f4e582ef57564450540242b0db766b78328
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PXMP4 SQLE CP ELF3 MUC1	1.13e-04	197	107	5	ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCell	Severe_COVID-19-Epithelial-transitional_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	PPIL6 CP RSPH1 ELF3 MUC1	1.13e-04	197	107	5	5ad3cd4c77016e862041baac3076f8cc0f75c417
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PPIL6 CP RSPH1 ELF3 MUC1	1.13e-04	197	107	5	08b371309cd790b171ed76cabc7d910e71cd2835
Drug	phensuximide	DPYS ELF3 CACNA1I	1.00e-06	5	107	3	CID000006839
Disease	lymphangioma (is_marker_for)	FLT4 KDR	1.23e-05	2	104	2	DOID:1475 (is_marker_for)
Disease	HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC	FLT4 KDR	1.23e-05	2	104	2	C4016109
Disease	Adenoid Cystic Carcinoma	PDZK1 INSRR CNTN6 ASPM MARK2	2.85e-05	100	104	5	C0010606
Disease	HEMANGIOMA, CAPILLARY INFANTILE	FLT4 KDR	3.68e-05	3	104	2	602089
Disease	Capillary infantile hemangioma	FLT4 KDR	3.68e-05	3	104	2	cv:C1865871
Disease	HEMANGIOMA, CAPILLARY INFANTILE	FLT4 KDR	3.68e-05	3	104	2	C1865871
Disease	Asterixis	PDYN CP	1.83e-04	6	104	2	C0232766
Disease	Oral Dyskinesia	PDYN CP	1.83e-04	6	104	2	C0454606
Disease	Ballismus	PDYN CP	1.83e-04	6	104	2	C0752196
Disease	Hemiballismus	PDYN CP	1.83e-04	6	104	2	C0221169
Disease	Lingual-Facial-Buccal Dyskinesia	PDYN CP	1.83e-04	6	104	2	C0152115
Disease	Involuntary Movements	PDYN CP	2.55e-04	7	104	2	C0427086
Disease	orofacial cleft (is_implicated_in)	MYH9 LOXHD1	2.55e-04	7	104	2	DOID:0050567 (is_implicated_in)
Disease	Dyskinetic syndrome	PDYN CP	2.55e-04	7	104	2	C0013384
Disease	beta-Ala-His dipeptidase measurement	ZNF254 ZNF675	3.40e-04	8	104	2	EFO_0008033
Disease	Chromosomal Instability	PPP2R5C PPP2R5E	3.40e-04	8	104	2	C1257806
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	LRP12 ST7 NT5DC2 MUC1	5.30e-04	105	104	4	EFO_0007788, EFO_0008007, EFO_0008343
Disease	Malignant neoplasm of salivary gland	PDZK1 ASPM MARK2	5.42e-04	45	104	3	C0220636
Disease	Salivary Gland Neoplasms	PDZK1 ASPM MARK2	6.16e-04	47	104	3	C0036095
Disease	thyroid gland carcinoma (is_marker_for)	FLT4 KDR	7.94e-04	12	104	2	DOID:3963 (is_marker_for)
Disease	systemic scleroderma (is_marker_for)	FLT4 KDR MUC1	8.77e-04	53	104	3	DOID:418 (is_marker_for)
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	HECW1 HSD17B3	1.09e-03	14	104	2	EFO_0004670, EFO_0006794
Disease	Schizophrenia	CACNB2 PDYN PDZK1 CP WDR11 EGR4 B3GAT1 KDR MARK2 TNXB	1.13e-03	883	104	10	C0036341
Disease	Tourette syndrome, schizophrenia	CACNA1I RERE	1.81e-03	18	104	2	EFO_0004895, MONDO_0005090
Disease	response to methotrexate, juvenile idiopathic arthritis	ANO4 CACNA1I	2.02e-03	19	104	2	EFO_0002609, GO_0031427
Disease	coagulation factor measurement	ASPM MCF2L	2.24e-03	20	104	2	EFO_0004634
Disease	number of teeth measurement	CACNB2 IGF2BP1	2.24e-03	20	104	2	EFO_0010073
Disease	response to alcohol	PCSK1 LRP12 ST7	2.39e-03	75	104	3	EFO_0005526
Disease	cortical surface area measurement	ANO4 DCDC1 STK17B TTC34 FMNL2 ZNF675 IGF2BP1 PPP2R5E NT5DC2 RERE HSD17B3 TNXB	2.77e-03	1345	104	12	EFO_0010736
Disease	spermatogenic failure (is_implicated_in)	WDR19 USP26	2.97e-03	23	104	2	DOID:0111910 (is_implicated_in)
Disease	otosclerosis	DPYS FMNL3 KDR	2.97e-03	81	104	3	EFO_0004213
Disease	odontogenesis	CACNB2 IGF2BP1	3.23e-03	24	104	2	GO_0042476

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFKGASRRQQQKYLG	USP26	616	Q9BXU7
IYGKFLGLRAFIRKQ	PPP2R5E	206	Q16537
LQRSQAYFKLRGVKG	B3GAT1	266	Q9P2W7
GQIKLADFGLARLYN	CDK12	871	Q9NYV4
SGRKKLQFAAGYRLN	CNTNAP1	426	P78357
ADHGNNKKGFRIRYI	CSMD3	2551	Q7Z407
QCGRRKGKQYRLGDF	CAPS2	351	Q9BXY5
KGFLEALGRLQKKFY	NT5C1A	251	Q9BXI3
YNGNARGKDFLALAL	AGRN	1411	O00468
GKFLGLRAYIRKQIN	PPP2R5C	191	Q13362
DGRRLVYKFGKNSSG	ELF3	346	P78545
KSNGLYFRDGKCRID	ANO4	106	Q32M45
RGYKGRQVFLRQKSA	ASPM	3041	Q8IZT6
FKRYKELQRLGLGNN	ASPN	261	Q9BXN1
NGKLSIYLGKRDFVD	ARR3	11	P36575
GAAAQSYGKGARRKN	CACNB2	36	Q08289
DKLFGKRLLQAGRYL	ANO8	36	Q9HCE9
GLRNGVYLAKLGNFF	IQGAP1	71	P46940
KLSKQEGQNYGFFLR	PDZK1	11	Q5T2W1
LQNGPDRIGRLYKKA	CP	56	P00450
AARRLYNEKGKEIFA	DCDC1	976	M0R2J8
NISRKGFRLAYFSGK	LRP12	146	Q9Y561
LKKLNRYSDGLLRFG	LZTS1	31	Q9Y250
LRNFYRKLEAKGFGQ	HECW1	1231	Q76N89
AQGRIYGKLKEENFF	IGF2BP1	466	Q9NZI8
NAAKIFNLYPRKGRI	DPYS	381	Q14117
YKQGGFLGLSNIKFR	MUC1	1081	P15941
YGARGNKNSGKIFLE	LOXHD1	321	Q8IVV2
GERYLGKSENRTNKF	LOXHD1	1286	Q8IVV2
GFALRDINKDRKDGY	FETUB	46	Q9UGM5
DKNELKQALSGFGYR	PDCD6	111	O75340
LKGKVLGFRYQDLRQ	KPTN	46	Q9Y664
DNQKRYGGFLRRQFK	PDYN	221	P01213
GEKLYQEARKILGAF	LPO	406	P22079
KSYLMNRLAGKRNGF	GBP4	66	Q96PP9
RGYLARKAFAKRQQQ	MYH9	791	P35579
VYGRNALNLKGFFIL	LRRC63	321	Q05C16
QKARAEERLKGLGFY	EGR4	566	Q05215
KAGFSQRGIRLHYKN	PPIL6	181	Q8IXY8
GRNFNYLKTGIRIKE	TENT4A	421	Q5XG87
QDDYQLVRKLGRGKY	CSNK2A3	36	Q8NEV1
LGFVYKLEGEKRQAA	IFIT5	441	Q13325
KYGNFIDKLRLFTRG	GTPBP10	11	A4D1E9
DLKGLRNAISEKYGF	GRHL3	536	Q8TE85
GLRNLINLGKNYEKA	BAIAP2L1	26	Q9UHR4
EGLGNLLKKRASFYE	DOCK5	1336	Q9H7D0
NRRLKKYALVDFGLA	CDC7	186	O00311
KRGAVYGFKLQSLDL	FMNL3	781	Q8IVF7
AKLRGIVDSKYFNRG	CACNA1I	631	Q9P0X4
QLRKACFLYFKLGGE	SQLE	486	Q14534
KTRLFQGLYKADQRF	ANKMY1	66	Q9P2S6
NLRGRNLAKGQLIFY	CNTN6	301	Q9UQ52
QDDYQLVRKLGRGKY	CSNK2A1	36	P68400
KRGAVYGFKLQSLDL	FMNL2	836	Q96PY5
GNYRLLKTIGKGNFA	MARK2	51	Q7KZI7
LKKRFAYLSGGRGQD	MCF2L	76	O15068
LKNKYGDAFIRGNNV	LSM6	56	P62312
VLAALGFFYGKKRNR	INSRR	936	P14616
KGKLQYELQYRNRGD	IL21R	151	Q9HBE5
ALGDKAIFAGRKFRN	ENO3	416	P13929
AKARAQLGYAPDKFR	SDR42E2	351	A6NKP2
GKAYSFELAKRGLNV	HSD17B3	61	P37058
GNKKYRALRLDVGNF	RPS8	51	P62241
QRIGLKYFGDFEKRI	POLB	136	P06746
VGKNQVRFGALKYAD	COL6A6	841	A6NMZ7
TLKNLGALYRRQGKF	KLC1	466	Q07866
LTIGNRLKDANKFGY	PARS2	416	Q7L3T8
GLENRHNYGRFEKKC	SPATA48	46	A4D263
FGGYLVKAEQKRGKR	TNNT1	161	P13805
DNKRYLFIQKLGEGG	STK16	16	O75716
KGRKAKALYDFRGEN	SH3D19	731	Q5HYK7
SVCREYFQNGGKRKA	BMT2	101	Q1RMZ1
IYGFGDQSNLRKLRN	SCCPDH	201	Q8NBX0
GALNGNYLKRKLQDA	FNBP4	571	Q8N3X1
GQEYAAKFLKKRRRG	STK17B	56	O94768
LGQRVRLKGFSKYRA	SIPA1L2	641	Q9P2F8
DGRLIFKGQYKDNIR	SETD7	101	Q8WTS6
KRYLQAGKFFLLCGQ	WDR19	1021	Q8NEZ3
KGLRQYGKNFFRIRK	RERE	406	Q9P2R6
FKNGARYIGEYVRNK	RSPH1	61	Q8WYR4
KQALKAGDGCYRRSQ	ST7	261	Q9NRC1
GQELRLRAYAKKGFG	POLR2C	156	P19387
GHYLDQKRLKQGLYR	ACLY	1071	P53396
RGASNKYLVEFRAGK	ADRM1	16	Q16186
KGAKRYGFTFLGNRN	ATP11C	506	Q8NB49
GFRKELRNLEAGYKS	USP53	751	Q70EK8
LDGKNVKAFYRRAQA	TOMM34	256	Q15785
AFRGYFKQGLVIRKG	VIL1	106	P09327
GRFIKYFVKGRQAVL	STK19	296	P49842
DDGKLYNGRAKGRQF	SPRYD3	121	Q8NCJ5
GRNYLLAFQKGIRNK	WDFY3	2636	Q8IZQ1
RGGEQLAKLKRNYAK	ATP6V1D	126	Q9Y5K8
KYGNLSNFLRAKRDA	FLT4	931	P35916
YKFLLFGIQDGKRRS	TNXB	1641	P22105
LGKNDGSVNGKRYFE	TBCB	201	Q99426
TRLEKGKIYRQGNLF	NT5DC2	326	Q9H857
GKIYRQGNLFDFLRL	NT5DC2	331	Q9H857
RRYEKCGNDNFQLKG	ZNF675	101	Q8TD23
LVRKGFDFQRKQYGK	ZGRF1	1431	Q86YA3
KGARFRQGKDYVGAI	KDR	941	P35968
AFVEDRKLYNLGLKG	TGS1	31	Q96RS0
NGKLRVKGIYYRNAD	UNQ5830/PRO19650/PRO19816	46	Q6UY13
AGQIRRLYGSNKKAD	TRMT10B	146	Q6PF06
ADYARSLKNLGFKQG	WDR11	1181	Q9BZH6
NKDGIQGSCRYFKER	GTF3C1	106	Q12789
KRNSRLGFLYDLDKQ	RIPOR1	111	Q6ZS17
KKANLNALDRYGRTA	POTEH	331	Q6S545
KGFRNGAVYGAKIRA	PXMP4	31	Q9Y6I8
RRGFFYDANQLVKKL	TTC34	96	A8MYJ7
LLARARCYGFLGQKK	TTC34	181	A8MYJ7
RYGKYGHENLQLRKG	ZNF254	111	O75437
GKGFLDLNRQLLDKY	TSR3	191	Q9UJK0
GRKYGSNVNRIKNLF	PPP1R9A	56	Q9ULJ8
GRLAQKAFEYGVKQG	PCSK1	281	P29120